Ultraviolet recall reaction after total body irradiation, etoposide, and methotrexate therapy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 17187896.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Ultraviolet (UV) reactivation reactions are rare and can occur in areas of prior sunburn or UV light therapy after the administration of chemotherapy, antibiotics, and other medications. Reactions may occur within days, as described after methotrexate therapy, or may appear months later, as described with ampicillin. Such reactions have been variably termed "UV recall," "sunburn recall," "photo recall," and "photodermatitis reactivation," making classification difficult. We report a UV reactivation reaction in a patient with acute lymphocytic leukemia treated with total body irradiation, etoposide, and methotrexate. We propose the terms "UV recall" and "UV enhancement" be used in future reports to classify UV reactivation reactions in a scheme analogous to the terminology for cutaneous reactions after radiotherapy.
Medical subject headings
- Antimetabolites, Antineoplastic
- Antineoplastic Agents, Phytogenic
- Etoposide
- Methotrexate
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Ultraviolet Rays
- Whole-Body Irradiation